Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 1/2017

01-01-2017 | Commentary

Emergency oncology: development, current position and future direction in the USA and UK

Authors: Tim Cooksley, Terry Rice

Published in: Supportive Care in Cancer | Issue 1/2017

Login to get access

Abstract

The need for supportive and palliative care services in patients with cancer is well established. However, the emerging unique challenges of acutely unwell patients with cancer necessitate the need for research into the optimal strategies and pathways for their management. The clinical challenges of emergency oncology alongside its increasing financial burden have led to an interest as to the best strategies for delivering this care. In the USA and UK, varying models of emergency and acute care are developing. There is a clear need for non-oncology physicians with an interest in the management of oncological emergencies to be at the heart of this work. This paper considers the current situation in the USA and UK and the future directions for the delivery of this care.
Literature
1.
2.
American Cancer Society 2014, Surveillance and Health Services Research
3.
Berger J, Cooksley T, Holland M (2013) The burden of cancer on the acute medical unit. Clin Med 13:457–459CrossRef
4.
Mansour D, Simcock R, Gilbert D (2011) Acute oncology service: assessing the need and its implications. Clin Oncol 23:168–173CrossRef
5.
6.
Cooksley T, Kitlowski E, Haji-Michael P (2012) Effectiveness of modified early warning score in predicting outcomes in oncology patients. QJM 105(11):1083–1088CrossRefPubMed
7.
Brown J, Grudzen C, Kyriacou J, et al. 2016, The emergency care of patients with cancer: setting the research agenda. Ann Emerg Med
8.
9.
Harrison JM, Stella PJ, Lavasseur B et al (2016) Toxicity-related factors associated with use of services among community oncology patients. Journal of Oncology Practice. doi:10.​1200/​JOP.​2016.​010959
10.
11.
Wattana M, Merriman K, Todd KH2013. Emergency department visits among cancer patients in Harris County, Texas (abstract). In: 7th annual mediterranean emergency medicine congress; Marseille, France
12.
Wathes R, Clifford A, Januszewki A, Urch C (2015) Transformation of oncology inpatients: effects on length of stay and patient satisfaction. Future Hosp Journal 2(3):162–165
13.
Putt L, Jones P (2013) The role of the specialist acute oncology nurse in the new acute oncology services. Clin Oncol 26(3):125–127CrossRef
14.
King J, Ingham-Clark C et al (2011) Towards saving a million bed days: reducing length of stay through an acute oncology model of care for inpatients diagnosed as having cancer. BMJ Qual Saf 20(8):718–724CrossRefPubMed
15.
Neville-Webb H, Carser J et al (2013) The impact of a new acute oncology service in acute hospitals: experience from the Clatterbridge Cancer Centre and Merseyside and Cheshire Cancer Network. Clin Med 13(6):565–569CrossRef
16.
Royal College of Physicians 2015. Acute care toolkit 7: acute oncology on the acute medical unit
17.
18.
Rice TW, Klotz A et al (2016) Models of emergency department care. In: Todd, Thomas Jr (eds) Oncologic emergency medicine: principles and practice. Springer, Berlin, pp. 3–12CrossRef
Metadata
Title
Emergency oncology: development, current position and future direction in the USA and UK
Authors
Tim Cooksley
Terry Rice
Publication date
01-01-2017
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 1/2017
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3470-1

Other articles of this Issue 1/2017

Supportive Care in Cancer 1/2017 Go to the issue

Erratum

Erratum to: Role of olanzapine in chemotherapy-induced nausea and vomiting on platinum-based chemotherapy patients: a randomized controlled study

Special Article

2016 Updated MASCC/ESMO consensus recommendations: Management of nausea and vomiting in advanced cancer

Original Article

What do adolescents and young adults want from cancer resources? Insights from a Delphi panel of AYA patients

Original Article

Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy

Special Article

2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy

Erratum

Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits